Page last updated: 2024-08-21

benzoxazoles and Polyneuropathies

benzoxazoles has been researched along with Polyneuropathies in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (80.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Anselmo, J; Coelho, T; Fernandes, J; Kelly, JW; Mesgarzadeh, JS; Monteiro, C; Novais, M; Powers, DL; Powers, ET; Rodrigues, C1
Cruz, MW1
Amass, L; Cameron, C; Salvo, EM; Samjoo, IA; Stewart, M; Tran, D1
Amass, L; Gundapaneni, B; Keohane, D; Schwartz, J; Stewart, M1
Castro, J; Conceição, I; de Carvalho, M; Miranda, B1
Kristen, AV1
Agarwal, S; Betts, M; Chitnis, M; Fahrbach, K; Gollob, J; Lin, H; Planté-Bordeneuve, V; Polydefkis, M1
Deeks, ED; Lamb, YN1
Cameron, C; Salvo, EM; Samjoo, IA; Tran, D1
Agarwal, S; Betts, M; Chitnis, M; Fahrbach, K; Lin, H; Polydefkis, M1

Reviews

4 review(s) available for benzoxazoles and Polyneuropathies

ArticleYear
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2019, Volume: 29, Issue:Suppl 1

    Topics: Amyloid Neuropathies, Familial; Autonomic Nervous System Diseases; Benzoxazoles; Humans; Polyneuropathies

2019
The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy.
    Current medical research and opinion, 2020, Volume: 36, Issue:5

    Topics: Adult; Amyloid Neuropathies, Familial; Bayes Theorem; Benzoxazoles; Female; Humans; Male; Middle Aged; Network Meta-Analysis; Oligonucleotides; Polyneuropathies; RNA, Small Interfering

2020
An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy.
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:4

    Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Humans; Polyneuropathies; Quality of Life; Randomized Controlled Trials as Topic; RNA, Small Interfering; Surveys and Questionnaires

2019
Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy.
    Drugs, 2019, Volume: 79, Issue:8

    Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Clinical Trials as Topic; Disease Progression; Drug Approval; Humans; Mutation; Polyneuropathies; Prealbumin; Quality of Life

2019

Trials

1 trial(s) available for benzoxazoles and Polyneuropathies

ArticleYear
Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2017, Volume: 24, Issue:1

    Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Disease Progression; Female; Humans; Male; Middle Aged; Polyneuropathies; Prealbumin; Treatment Outcome

2017

Other Studies

5 other study(ies) available for benzoxazoles and Polyneuropathies

ArticleYear
Tafamidis polyneuropathy amelioration requires modest increases in transthyretin stability even though increases in plasma native TTR and decreases in non-native TTR do not predict response.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2023, Volume: 30, Issue:1

    Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Humans; Male; Polyneuropathies; Prealbumin

2023
Hereditary amyloidosis related to transthyretin V30M: disease progression in treated and untreated patients.
    European journal of neurology, 2018, Volume: 25, Issue:11

    Topics: Adult; Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Disease Progression; Female; Humans; Liver Transplantation; Male; Middle Aged; Neural Conduction; Polyneuropathies; Time Factors; Treatment Outcome

2018
[What gnaws at the heart and gets on the nerves].
    Der Internist, 2018, Volume: 59, Issue:11

    Topics: Aged; Amyloid; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Drug Approval; Humans; Middle Aged; Mutation; Polyneuropathies; Prealbumin; Quality of Life

2018
Letter to the editor concerning the article: "An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy".
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:12

    Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Humans; Polyneuropathies; Prealbumin; RNA, Small Interfering

2019
Response to the letter to the editor on "an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy".
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:12

    Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Humans; Polyneuropathies; Prealbumin; RNA, Small Interfering

2019